Combination of Oral Decitabine/Cedazuridine and Venetoclax in Patients with Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
Year: 2023
Type: preprint
Study design: Clinical Trial
Source: SSRN Electronic Journal
DOI: 10.2139/ssrn.4577477
Authors: Alex Bataller Torralba, Guillermo Montalban-Bravo, Alexandre Bazinet, Yesid Alvarado, Kelly Chien, Sangeetha Venugopal, Jo Ishizawa, Danielle Hammond, Mahesh Swaminathan, Koji Sasaki, Ghayas Issa, Nicholas Short, Lucia Masarova, Naval Daver, Tapan Kadia, Simona Colla, Wei Qiao, Xuelin Huang, Rashmi Kanagal-Shamanna, Stephany Hendrickson, Farhad Ravandi, Elias Jabbour, Hagop Kantarjian, Guillermo Garcia-Manero
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W4386923661